Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 3/20 | 0.39 |
| ▸ | CDC25A | P30304 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | PTPRC | P08575 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | BCHE | P06276 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1506869 | 0.89 | ABCG2 (0.35) | CDC25BCDC25AMEN1KMT2APTPRC | |
| SCHEMBL28494770 | 0.80 | POLB (0.33) | KDM4EPOLBMAPTALDH1A1ABCG2 | |
| SCHEMBL3444897 | 0.77 | CDC25B (0.57) | CDC25BCDC25AMEN1KMT2APTPRC | |
| SCHEMBL7119051 | 0.73 | CDC25B (0.53) | CDC25BCDC25AMEN1KMT2APTPRC | |
| SCHEMBL30851365 | 0.71 | TDP2 (0.36) | CDC25BMEN1KMT2APTPRCKDM4E | |
| SCHEMBL7915389 | 0.70 | PTPRC (0.46) | CDC25BCDC25AMEN1KMT2APTPRC | |
| SCHEMBL29534849 | 0.70 | PTPRC (0.46) | CDC25BCDC25AMEN1KMT2APTPRC | |
| SCHEMBL1408501 | 0.70 | BACE1 (0.64) | CDC25BCDC25AMEN1KMT2APTPRC | |
| SCHEMBL1899000 | 0.68 | ABCG2 (0.31) | ABCG2 | |
| SCHEMBL29372537 | 0.68 | ABCG2 (0.31) | ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010056085-A1 | Methods of using vesicant drug formulations | RAMU AVNER (US) | 2001-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010056085-A1 | Methods of using vesicant drug formulations | UGT1A1, SLC47A1, UGT1A10 | CDC25B 803/4885CDC25A 1010/4885MEN1 2517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.